Potential adjunct therapies for the management of temporomandibular disorders: An evidence-based review

S Dadjoo, D Michelogiannakis, PE Rossouw, F Javed - CRANIO®, 2022 - Taylor & Francis
CRANIO®, 2022Taylor & Francis
Objective The aim was to review the role of adjuvant therapies that may potentially
contribute toward the management of temporomandibular disorders (TMD). Methods The
addressed focused question was,“Are there any adjuvant therapies that may contribute
toward the management of TMD?”. Indexed databases were searched up to June 2021. The
eligibility criteria were the following:(a) original clinical studies and (b) randomized
controlled clinical trials (RCTs). Results Adjuvant therapies were comprised of acupuncture …
Objective
The aim was to review the role of adjuvant therapies that may potentially contribute toward the management of temporomandibular disorders (TMD).
Methods
The addressed focused question was, “Are there any adjuvant therapies that may contribute toward the management of TMD?”. Indexed databases were searched up to June 2021. The eligibility criteria were the following: (a) original clinical studies and (b) randomized controlled clinical trials (RCTs).
Results
Adjuvant therapies were comprised of acupuncture, manual therapy, jaw exercises, dietary modifications, botulinum toxin therapy, and photobiomodulation. Short-term follow-up results from each of these RCTs showed beneficial effects in terms of pain reduction and improvements in jaw movement among patients with TMD. There are no long-term follow-up results in this regard.
Conclusion
The most effective adjunct treatment for managing TMD remains unknown, primarily due to a lack of sufficient scientific evidence.
Taylor & Francis Online
以上显示的是最相近的搜索结果。 查看全部搜索结果